Jun 2, 2026 07:21AM
Jun 2, 2026 07:19AM
May 29, 2026 06:07AM
May 12, 2026 09:59AM
May 11, 2026 05:11PM
May 11, 2026 04:44PM
May 7, 2026 08:04AM ArriVent receives FDA clearance for ARR-002 cancer drug trial
Apr 24, 2026 05:06AM
Mar 11, 2026 04:07PM
Jan 16, 2026 07:04AM
Jan 6, 2026 06:03AM
Dec 22, 2025 04:05PM
Dec 10, 2025 06:36AM
Nov 25, 2025 06:03AM Truist Securities Starts ArriVent BioPharma (AVBP) at Buy, PT $43
Nov 10, 2025 07:40AM
Aug 12, 2025 06:41AM
Aug 11, 2025 04:21PM
Jul 22, 2025 06:39AM
Jul 21, 2025 09:12AM
Jul 10, 2025 06:23AM
Jul 3, 2025 06:12AM Clear Street Reiterates Buy Rating on ArriVent BioPharma (AVBP)
Jul 1, 2025 04:05PM
Jun 30, 2025 06:50AM
Jun 24, 2025 04:20PM
Jun 23, 2025 12:47PM
Jun 23, 2025 07:03AM
May 14, 2025 07:52AM
May 12, 2025 08:01AM ArriVent BioPharma, Inc. (AVBP) Misses Q1 EPS by 117c
Apr 28, 2025 08:02AM
Mar 20, 2025 02:20AM
Mar 7, 2025 06:42AM
Mar 3, 2025 01:39PM
Feb 3, 2025 07:08AM
Nov 15, 2024 07:13AM
Sep 10, 2024 11:49AM ArriVent BioPharma (AVBP) PT Raised to $36 at Citi
Sep 10, 2024 06:39AM
Sep 10, 2024 06:22AM
Sep 9, 2024 12:07PM
Aug 16, 2024 06:42AM
Aug 12, 2024 08:11AM
Jul 22, 2024 07:05AM

405,006 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All